Long Noncoding RNA H19 Overexpression Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting

Xuelin Liu1,2, Qian Zhang1,2, Yuemei Zhang2

  • 1Department of Cardiology, Gansu Provincial Central Hospital, Lanzhou, 730070, Gansu, China.

Biochemical Genetics
|October 2, 2025
PubMed

Insights

Long non-coding RNA H19 protects against diabetic cardiomyopathy by regulating miR-138-5p and mitochondrial calcium uniporter (MCU). This pathway reduces oxidative stress in heart cells, offering potential therapeutic targets for diabetic heart disease.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Biochemistry

Background:

  • Diabetic cardiomyopathy (DCM) involves mitochondrial oxidative stress.
  • Long non-coding RNAs (lncRNAs) play roles in cellular regulation.
  • The H19 lncRNA and miR-138-5p microRNA are implicated in various cellular processes.

Purpose of the Study:

  • To investigate the regulatory role of lncRNA H19 on miR-138-5p.
  • To determine the impact of the H19/miR-138-5p axis on mitochondrial oxidative stress in DCM.
  • To elucidate the molecular mechanisms underlying DCM pathogenesis.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) for gene expression analysis.
  • In vitro diabetic cardiomyopathy model using high glucose-exposed H9c2 cardiomyocytes.
  • Dual-luciferase reporter assays to confirm targeting relationships.
  • Western blotting for protein expression analysis.
  • Measurement of reactive oxygen species (ROS), superoxide dismutase (SOD), and malondialdehyde (MDA) to assess oxidative stress.

Main Results:

  • In the DCM model, H19 and mitochondrial calcium uniporter (MCU) were downregulated, while miR-138-5p was upregulated.
  • H19 overexpression reduced oxidative stress markers (ROS, MDA) and increased antioxidant activity (SOD) in high glucose-treated cells.
  • miR-138-5p was validated to target both H19 and MCU, suppressing MCU protein expression.
  • Rescue experiments confirmed that miR-138-5p overexpression or MCU silencing reversed the protective effects of H19.

Conclusions:

  • lncRNA H19 attenuates mitochondrial oxidative stress in diabetic cardiomyopathy by modulating the miR-138-5p/MCU axis.
  • The H19/miR-138-5p/MCU pathway is a key mechanism in DCM pathogenesis.
  • H19 shows potential as a diagnostic biomarker and therapeutic target for diabetic cardiomyopathy.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K